Large-scale testing (Phase 3)Study completedNCT00253201
What this trial is testing
The Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease
Who this might be right for
Alzheimer DiseaseDementia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 636